CCI-007, a novel small molecule with cytotoxic activity against infant leukemia with MLL rearrangements

SUPPLEMENTARY FIGURES Supplementary
: Effect of CCI-007 treatment on cell cycle progression. Cell cycle analysis was performed on CCI-007 sensitive PER-485 cells A. and CCI-007 resistant MLL-wt REH cells B. treated with 5 µM CCI-007, vehicle control or 0.4 μg/ml VP16 (as a positive control for cell cycle block) for up to 72h using propidium iodide staining followed by flow cytometry. The percentages of cells in G 0 /G 1 , S and G 2 cell cycle phases are shown in the bar graphs representing mean ± SE of 3 independent experiments. Mean percentages of cells per phase between treatments were compared by t-tests. **, P<0.01. Figure S2 : CCI-007 treatment lowers HOXA9, MEIS1 and CMYC mRNA levels in CCI-007 sensitive cell lines MV4;11, KP-MO-TS and MOLM-13. Effect of CCI-007 treatment on HOXA9, MEIS1 and CMYC mRNA levels in sensitive MV4;11 (MLL-AF4), MOLM-13 (MLL-AF9) and KP-MO-TS (CALM-AF10) cells. Cells were treated with 5 μM CCI-007 (MV4;11 and KP-MO-TS) or 10 μM CCI-007 (MOLM-13) for 3h. mRNA levels were assayed by quantitative real-time RT-PCR and relative expressions were calculated using the ΔΔCt method. Gene expressions were normalized against housekeeping genes and expressed relative to DMSO vehicle control. Each data point represents the mean ± SE of at least 3 independent experiments. Mean relative expressions between treatment groups were compared by t-tests. **, P<0.01; ***, P<0.001; ****, P<0.0001. Supplementary Figure S4 : CCI-007 decreases mRNA expression of MLL target genes independent from caspasedependent apoptosis. CCI-007 treatment induces a reduction in MLL target gene mRNA levels when caspase-dependent apoptosis is inhibited. PER-485 were pre-treated with 10 µM pan-caspase inhibitor Q-VD-OPh for 2h prior to treatment with 5 µM CCI-007 for 3h. mRNA levels were assayed by quantitative real-time RT-PCR and relative expressions were calculated using the ΔΔCt method. Gene expressions were normalized against housekeeping genes and expressed relative to DMSO vehicle control. Samples were run in triplicate in each assay. Each data point represents the mean ± SE of 3 experiments. ANOVA was performed to compare mean relative expressions of genes between treatment groups. *, P<0.05; **, P<0.01; ***, P<0.001; ****, P<0.0001.
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